
Management of acute urinary retention in men with benign prostatic hyperplasia: Literature review and guidelines from the French Urological Association Male LUTS Panel (CTMH)
UrologiaResumo original em inglês
O que aconteceu
Acute urinary retention (AUR) is a common urological emergency, particularly in elderly men, often associated with benign prostatic hyperplasia (BPH). It requires prompt intervention to relieve symptoms and prevent complications. The French Urological Association Male LUTS Panel (CTMH) aimed to develop evidence-based guidelines for managing BPH-related AUR in men.
A systematic PubMed literature review was conducted, evaluating studies by level of evidence and methodological quality. Guidelines were developed through CTMH member consensus.
O que encontraram
Drainage method selection (urethral or suprapubic catheter) should consider patient-specific contraindications. Suprapubic catheterization may offer superior patient comfort and reduced colonization rates. Clean intermittent self-catheterization represents a viable alternative with improved quality of life. Alpha-blockers (alfuzosin 10mg, tamsulosin 0.4mg, silodosin 8mg) administered for 2-3days significantly improve trial without catheter success rates, with no agent demonstrating superiority. Short catheterization duration (60, known BPH). Evidence remains insufficient to recommend immediate surgery without trial without catheter or to establish optimal surgical technique.
Por que isso importa
These CTMH guidelines provide evidence-based recommendations for AUR management, emphasizing alpha-blocker therapy before trial without catheter and considering patient-specific factors when selecting drainage methods. Further research is needed to optimize surgical timing and technique selection.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Management of acute urinary retention in men with benign prostatic hyperplasia: Literature review and guidelines from the French Urological Association Male LUTS Panel (CTMH)
Ugo Pinar, Jérome Gas, Clément Sarrazin, Julien Anract, Armand Chevrot, Hakim Fassi-Fehri, Jonas Wilisch, Yohann Rouscoff, Emmanuel Della Negra, Clément Klein et al.
Descritores MeSH
- Prostatic Hyperplasia
- Urinary Retention
- Adrenergic alpha-Antagonists
- Humans
- Tamsulosin
- Urinary Catheterization
- Male
- Acute Disease
Veja também
Estudos relacionados
- Effectiveness and safety of intermittent catheterisation for the management of acute urinary retention: A prospective, randomised, multicentre, controlled study
- Does the duration of catheterization have an impact on the outcome of trial without catheter in patients with acute urine retention (AUR) due to benign prostatic hyperplasia (BPH)? A prospective randomized study
- Efficacy and safety of intermittent catheterization for acute urinary retention: a prospective comparative randomized study
- Eficácia e segurança dos antagonistas dos receptores α1-adrenérgicos no tratamento da retenção urinária aguda secundária a hiperplasia prostática benigna: uma revisão sistemática e metanálise de ensaios controlados randomizados